Imagion Biosystems has made the attached Appendix 3Y announcements in relation to change of Directors interest notice.
Read Appendix 3Y — Change in Director’s Interest Notice for
Home » Appendix 3Y — Change in Director’s Interest Notice
Imagion Biosystems has made the attached Appendix 3Y announcements in relation to change of Directors interest notice.
Read Appendix 3Y — Change in Director’s Interest Notice for
Highlights Blinded review by panel of expert breast radiologists corroborates potential for MagSense® nanoparticle technology to detect tumour cells in lymph nodes by Magnetic Resonance
Highlights: Imagion presented results from MagSense® HER2 Phase I study at global breast cancer meeting showing safety and detectability Tasks expert panel of radiologists with
Highlights: Imagion presented prostate cancer research data at World Molecular Imaging Conference (WMIC) Receipt of $2.5 million R&D tax incentive (post-quarter end) MELBOURNE – Imagion
We’re on a mission to make cancer more detectable.
Stay informed about our latest news and developments.
© Imagion Biosystems, Ltd. All Rights Reserved | Privacy Policy | Terms & Conditions | Careers | Corporate Governance